Skip to main content

Table 2 Univariable Cox regression model

From: Biochemical but not imaging parameters are predictive of outcome in septic shock: a pilot study

Variables

S group (n = 20)

NS group (n = 15)

P

HR

95%CI

Age, years

56 (46; 68)

64 (54; 73)

0.203

1.027

0.986–1.071

Gender F, n (%)

9 (45%)

5 (33%)

0.563

0.728

0.249–2.131

GSH RB, μmol/L

410 (318; 561)

392 (202; 518)

0.370

0.998

0.995–1.002

GSH TP, μmol/L

4.24 (2.118; 6.228)

2.73 (2.18; 4.18)

0.200

0.833

0.630–1.102

Hcy TP, μmol/L

8.03 (5.92; 14.13)

9.40 (5.48; 15.40)

0.681

1.013

0.952–1.078

CysGly TP, μmol/L

35 (25; 47)

29 (20; 36)

0.454

0.987

0.953–1.022

Cys TP, μmol/L

147 (100; 206)

168 (108; 232)

0.708

1.001

0.998–1.003

MDA, mmol/L

147 (97; 184)

206 (120; 261)

0.074

1.004

1.000–1.008

3-NT nmol/L

12.33 (7.12; 22.65)

12.33 (6.70; 38.10)

0.688

0.999

0.994–1.004

uNEO, μmol/mmol Creat

1.068 (0.528; 1.908)

1.344 (0.822; 3.436)

0.099

1.212

0.964–1.524

IL-6 pg/mL

446 (49; 2540)

1198 (180; 8646)

0.146

1.000

1.000–1.000

sIL-6R pg/mL

31,136 (20,251; 51,166)

33,157 (10,896; 38,651)

0.185

1.000

1.000–1.000

sGP-130 ng/mL

236 (202; 286)

200 (170; 307)

0.685

0.999

0.991–1.006

Ang-1 pg/mL, (500-fold increment)

10,200 (4614; 31,953)

11,062 (4480; 28,900)

0.848

0.999

0.985–1.013

Ang-2 pg/mL, (500-fold increment)

26,950 (10,822; 43,840)

49,048 (33,483; 64,293)

0.003

1.007

1.002–1.012

TnT, ng/L

105 (36; 289)

91 (50; 160)

0.495

1.000

1.000–1.000

NTproBNP, ng/L

19,359 (1991; 31,044)

7558 (3150; 28,820)

0.679

1.000

1.000–1.000

PCT, ng/mL

34 (11; 100)

35 (9; 70)

0.696

0.997

0.983–1.011

PWV, cm/sec

10.3 (8.7; 11.8)

10.8 (8.4; 11.7)

0.931

1.009

0.829–1.228

AX, %

8 (−7; 33)

12 (4; 15)

0.840

1.003

0.974–1.033

VTD, ml

108 (82; 116)

93 (60; 108)

0.220

0.985

0.961–1.009

VTS, ml

39 (32; 49)

39 (29; 61)

0.962

1.001

0.967–1.035

Dtd, mm

49 (41; 54)

45 (40; 49)

0.185

0.926

0.826–1.038

EF, %

55 (40; 64)

55 (39; 61)

0.702

0.992

0.952–1.034

MAPSE, mm

12.5 (12.0; 15.5)

12.5 (11.5; 14.3)

0.779

0.965

0.752–1.239

E, cm/sec

91 (56; 116)

85 (65; 90)

0.466

0.989

0.962–1.018

A, cm/sec

73 (40; 110)

90 (64; 111)

0.472

1.009

0.985–1.032

E/e’

8.55 (5.75; 12.93)

7.40 (5.95; 13.10)

0.998

1.000

0.833–1.201

Left atrial area, cm2

21 (17; 26)

19 (17; 23)

0.277

0.920

0.792–1.069

TAPSE, mm

20 (16; 23)

19 (15; 23)

0.958

0.997

0.877–1.132

PAPs, mmHg

36 (35; 46)

34 (30; 41)

0.277

0.941

0.844–1.050

  1. Data are expressed as median and interquartile range (I-III). GSH glutathione, Hcy homocysteine, CysGly cysteinilglycine, Cys cysteine, TP total plasma, RB reduced blood, MDA malondialdehyde, 3-NT 3-nitrotyrosine, uNEO urinary neopterin, IL-6 interleukin-6, sIL-6R soluble IL-6 receptor, sGP-130 soluble GP-130, Ang-1 and -2 angiopoietin-1 and-2, TnT Troponin T, NT-proBNP pro B-type natriuretic peptide, PCT pro-calcitonin, PWV pulse wave velocity, AX augmentation index, VTD and VTS telediastolic and telesystolic volumes, EF ejection fraction, MAPSE mitral anular plane excursion, TAPSE tricuspid anular plane excursion, S survivors, NS non-survivors